(Q44679857)

5 December 2017

title

Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis (English)

1 reference

5 December 2017

1 reference

2

Karl Claxton

1 reference

5 December 2017

Claire McKenna

1

1 reference

5 December 2017

publication date

10 March 2011

1 reference

5 December 2017

published in

Medical Decision Making

1 reference

5 December 2017

volume

31

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

853-865

1 reference

Dangerous omissions: the consequences of ignoring decision uncertainty

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Using value of information analysis to prioritise health research: some lessons from recent UK experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

21 January 2018

Information Value Theory

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Sensitivity analysis and the expected value of perfect information

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

An iterative Bayesian approach to health technology assessment: application to a policy of preoperative optimization for patients undergoing major elective surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Value-of-information analysis to guide future research in colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

The half-life of truth: what are appropriate time horizons for research decisions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Expected value of sample information calculations in medical decision modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Expected value of sample information for Weibull survival data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Dimensions of design space: a decision-theoretic approach to optimal research design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Value of information analysis used to determine the necessity of additional research: MR imaging in acute knee trauma as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Enhanced external counterpulsation for refractory angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Efficacy of enhanced external counterpulsation in the treatment of angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

On the (near) equivalence of cost-effectiveness and cost-benefit analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Expected value of information and decision making in HTA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

The value of information and optimal clinical trial design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Discounting and decision making in the economic evaluation of health-care technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

Incorporating option values into the economic evaluation of health care technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X11399921

21 January 2018

Identifiers

DOI

10.1177/0272989X11399921

1 reference

5 December 2017

1 reference